Metallic stent in the treatment of ureteral obstruction: Experience of single institute

Journal of the Chinese Medical Association

Volumn 74, Issue 10, 2011, Pages 460-463

  Li, Chien Chang ^a   Li, Jian Ri ^a,b   Huang, Li Hua ^a   Hung, Siu Wan ^a   Yang, Cheng Kuang ^a   Wang, Shiang Shian ^a   Chen, Chuan Su ^a   Ou, Yen Chuan ^a   Ho, Hao Chung ^a   Su, Chung Kuang ^a   Chen, Wen Ming ^a   Cheng, Chen Li ^a   Yang, Chi Rei ^a   Chiu, Kun Yuan ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Double J stent; Metallic stent; Radiotherapy; Ureteral obstruction

Indexed keywords

CREATININE;

ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CREATININE BLOOD LEVEL; CYSTOSCOPY; ECHOGRAPHY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MALE; NEPHROSTOMY; OUTCOME ASSESSMENT; PERCUTANEOUS NEPHROSTOMY; RADIOTHERAPY; RISK ASSESSMENT; STENOSIS; STENT; TREATMENT FAILURE; TREATMENT OUTCOME; URETER OBSTRUCTION; URETEROSCOPY; UTERINE CERVIX CANCER;

FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; URETERAL OBSTRUCTION;

EID: 80955128694     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.08.017     Document Type: Article

References (16)

1. Barbalias G.A., Liatsikos E.N., Kalogeropoulou C., Karnabatidis D., Zabakis P., Athanasopoulos A., et al. Externally coated ureteral metallic stents: an unfavorable clinical experience. Eur Urol 2002, 42:276-280.
2. Kouba E., Wallen E.M., Pruthi R.S. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. J Urol 2008, 180:444-450.
3. Ku J.H., Lee S.W., Jeon H.G., Kim H.H., Oh S.J. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?. Urology 2004, 64:895-899.
4. Ganatra A.M., Loughlin K.R. The management of malignant ureteral obstruction treated with ureteral stents. J Urol 2005, 174:2125-2128.
5. Yossepowitch O., Lifshitz D.A., Dekel Y., Gross M., Keidar D.M., Neuman M., et al. Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol 2001, 166:1746-1749.
6. Chung S.Y., Stein R.J., Landsittel D., Davies B.J., Cuellar D.C., Hrebinko R.L., et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 2004, 172:592-595.
7. Rosevear H.M., Kim S.P., Wenzler D.L., Faerber G.J., Roberts W.W., Wolf J.S. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan. Urology 2007, 70:846-850.
8. Pauer W., Eckerstorfer G.M. Use of self-expanding permanent endoluminal stents for benign ureteral strictures: mid-term results. J Urol 1999, 162:319-322.
9. Liatsikos E.N., Karnabatidis D., Katsanos K., Kallidonis P., Constantinides C., Perimenis P., et al. Metal stents for the management of malignant ureteral obstruction. J Endourol 2008, 22:2099-2100.
10. Barbalias G.A., Siablis D., Liatsikos E.N., Karnabatidis D., Yarmenitis S., Bouropoulos K., et al. Metal stents: a new treatment of malignant ureteral obstruction. J Urol 1997, 158:54-58.
11. Liatsikos E., Kallidonis P., Kyriazis I., Constantinidis C., Hendlin K., Stolzenburg J.U., et al. Ureteral obstruction: is the full metallic double-pigtail stent the way to go?. Eur Urol 2010, 57:480-486.
12. Wah T.M., Irving H.C., Cartledge J. Initial experience with the Resonance® metallic stent for antegrade ureteric stenting. Cardiovasc Intervent Radiol 2007, 30:705-710.
13. Bladou F., Houvenaeghel G., Delpéro J.R., Guérinel G. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. J Surg Oncol 1995, 58:91-96.
14. Fujikawa K., Miyamoto T., Ihara Y., Matsui Y., Takeuchi H. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women. Gynecol Oncol 2001, 80:21-23.
15. Milano M.T., Constine L.S., Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007, 17:131-140.
16. Nagele U., Kuczyk M.A., Horstmann M., Hennenlotter J., Sievert K.D., Schilling D., et al. Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis. World J Urol 2008, 26:257-262.